Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?

Published:2023-12 Issue: Volume: Page:
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Lemaitre Florian,Florentin Virginie,Blin Olivier,Bayle Arnaud,Benito Sylvain,Chauny Jean-Vannak,Galaup Ariane,Korchagina Daria,Lang Marie,Le Tourneau Christophe,Pelloux Hervé,Picard Nicolas,Guilhaumou Romain

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference16 articles.

1. The path to personalized medicine;Hamburg;N Engl J Med,2010

2. Rapport « Personalized Medicine at FDA – the Scope & Significance of Progress in 2022 »,2023

3. Cancer drug development forum. Innovation in oncology clinical trial design;Verweij;Cancer Treat Rev,2019

4. New clinical trial designs in the era of precision medicine;Garralda;Mol Oncol,2019

5. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment;Lengliné;Lancet Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP